Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
2015 · Oncotarget · 106 citations
https://doi.org/10.18632/oncotarget.6373
First Affiliated Hospital of Xinxiang Medical University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
713
Citations
11
h-index
11
i10-index
Xiaona Mao is an academic researcher from First Affiliated Hospital of Xinxiang Medical University. The author has contributed to research in topics: Cancer Cells and Metastasis & Metabolism, Diabetes, and Cancer & Hippo pathway signaling and YAP/TAZ. The author has an h-index of 11, co-authored 14 publications.
https://doi.org/10.18632/oncotarget.6373
https://doi.org/10.1038/cddis.2016.478
Click to start Chat